Skip to main content
. 2015 Jun 30;4(7):374–385. doi: 10.1002/psp4.48

Figure 1.

Figure 1

Schematic representation of the integrated simulation framework that was developed. PSA, prostate-specific antigen; LYG, life years gained; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life years; PK, pharmacokinetics.